|
Centre Makes Use Of Auto Disable Syringes Mandatory In Govt.
Hospitals From April 2009
Close on the heels of launching a nationwide intensive public awareness campaign
on unsafe injections, Marc Koska, founder of the SafePoint Trust UK in pursuit
of its mandate in implementing use of only auto disable syringes, has managed to
convince the Government of India which has now made it mandatory to use only
auto disable syringes from April 2009.
The action came in the wake of nationwide study conducted by the IndiaCLEN
Program Evaluation Network on behalf of the Ministry of Health and World Bank,
entitled ‘Assessment of Injection Practices in India’ in 2002-05 which brought
to light that in India nearly two thirds of the injections are administered in
an unsafe manner and also all the injection administered in India, one third
carry a potential risk of transmitting Blood Borne Virus.
MarcKoska, founder SafePoint saw the alarming state of unsafe injections in
India launched a nationwide campaign which started on November 14, 2008.
Koska finally got an invitation to discuss these issues with the Union Minister
of Health Ambumani Ramdoss and Dr R K Srivastava, director general of Health
Services and A Johari, joint secretary.
SafePoint managed to convince the government that it was high time to make all
injections safer with a combination of new technologies like safer auto disable
syringes combined with a batter informed public. Dr Ramdoss agreed that enough
is enough and that from April 1, 2009, all Central Government hospitals under
CGHS will switch over completely to Auto Disable syringes complying with
existing ISO standard across all sectors.
Dr Ramdoss immediately announced his intention to send letters to all chief
minister and governors of all States of adhering to safe injection practices
with the compulsory use of auto safe syringes at all Central Government
hospitals and state owned public health facilities. The true will also be made
mandatory for all privately owned hospitals and clinics in the second phase.
(Ref : Chronicle Pharmabiz dated December 18, 2008)
Baxter India Launches Renal Home Care
Baxter India has announced the launch of Renal Home Care (RHC), an integrated
patient care system that brings together highly trained counselors, clinical and
technical services team to provide patient care to renal patients.
It will facilitate better and more frequent contact with those on peritoneal
dialysis (PD), provide easy accessibility to renal dietician, besides supporting
and addressing the product delivery and distribution enquiries. It will also
update nephrologists on Baxter therapy and product information. RHC counselors
can be reached at 180 010 211 10, the toll free number.
"This initiative is launched in pursuit of making a meaningful difference in the
lives of patients with end stage renal disease (ESRD). It is a continuation of
the company’s ongoing efforts to improve patient care and enhance quality of
life of patients," said general manager of Baxter India, Raj Airey at a press
conference here on Thursday.
Every year, nearly 1.5 lakh new ESRD patients are diagnosed in India who join an
increasing patient population, of these only five to seven percent are able to
get some form of treatment, while the rest succumb to the disease without
getting any definite healthcare intervention, according to AIIMS and Indian
Council of Medical Research (ICMR) report.
Baxter India, a wholly-owned subsidiary of Baxter International Inc, claimed
that the company was committed to meaningful intervention in the lives of
patients going through trauma of hemophilia, immune disorders, kidney disease
and trauma. The latest venture is one of the initiatives to this direction.
(Ref : Chronicle Pharmabiz dated December 4, 2008) |
